Draupnir Bio
Description: Draupnir Bio develops small molecule PCSK9 modulators to lower LDL cholesterol and reduce heart disease risk.
Country: Denmark
Based in: Risskov, Midtjylland
Founded: 2017
Funding Stage: Seed
Tags: ['Biotechnology', 'Health Care', 'Pharmaceutical', 'Therapeutics']
ACCESS DIRECTORY
Details about how we process your information are available in our Privacy Policy.